Event Title
Hormonal Contraceptive Use and Postpartum Depression: Results from the Pregnancy Risk Assessment Monitoring System, 2016-2020
Location
Loosemore Auditorium
Description
PURPOSE: There is little known and previous literature does not well-establish the risks of postpartum hormonal contraceptive (HC) use and postpartum depression (PPD) outcomes. The aim of this study was to examine if HC use in the postpartum period is associated with the prevalence of PPD. SUBJECTS: The target population was women ages 18-45 following a recent live birth in the U.S from 2016-2020. The final sample size included 104,808 women. METHODS: This retrospective serial cross-sectional analysis used data from the Pregnancy Assessment Monitoring System (PRAMS), a national surveillance system overseen by the CDC. ANALYSES: Complex survey weighting procedures were used to provide descriptive statistics overall and by maternal characteristics. For participants using HCs, adjusted odds ratios (aOR) were calculated using logistic regression models to evaluate the association of HC use (yes, no) and type (short-acting, long-acting) with PPD. RESULTS: Overall, 12.11% (95 % CI: 11.80-12.42) of participants reported PPD. Prevalence of postpartum HC use was 53.42% (95% CI: 52.94-53.89). The use of short-acting contraceptives was more common among women taking a HC postpartum (60.19% (95% CI: 59.55, 60.82)). After adjusting for confounders, overall women using postpartum HCs were found to have decreased odds of PPD (aOR: 0.92; 95%CI: 0.87-0.98). Among women taking HCs, women taking long-acting contraceptives were more likely to experience PPD than short-acting users (aOR: 1.13; 95% CI: 1.04-1.22). CONCLUSION: Over half of recent mothers take HCs in the postpartum period. Understanding how different types of HCs impact maternal mental health can improve future postpartum care.
Hormonal Contraceptive Use and Postpartum Depression: Results from the Pregnancy Risk Assessment Monitoring System, 2016-2020
Loosemore Auditorium
PURPOSE: There is little known and previous literature does not well-establish the risks of postpartum hormonal contraceptive (HC) use and postpartum depression (PPD) outcomes. The aim of this study was to examine if HC use in the postpartum period is associated with the prevalence of PPD. SUBJECTS: The target population was women ages 18-45 following a recent live birth in the U.S from 2016-2020. The final sample size included 104,808 women. METHODS: This retrospective serial cross-sectional analysis used data from the Pregnancy Assessment Monitoring System (PRAMS), a national surveillance system overseen by the CDC. ANALYSES: Complex survey weighting procedures were used to provide descriptive statistics overall and by maternal characteristics. For participants using HCs, adjusted odds ratios (aOR) were calculated using logistic regression models to evaluate the association of HC use (yes, no) and type (short-acting, long-acting) with PPD. RESULTS: Overall, 12.11% (95 % CI: 11.80-12.42) of participants reported PPD. Prevalence of postpartum HC use was 53.42% (95% CI: 52.94-53.89). The use of short-acting contraceptives was more common among women taking a HC postpartum (60.19% (95% CI: 59.55, 60.82)). After adjusting for confounders, overall women using postpartum HCs were found to have decreased odds of PPD (aOR: 0.92; 95%CI: 0.87-0.98). Among women taking HCs, women taking long-acting contraceptives were more likely to experience PPD than short-acting users (aOR: 1.13; 95% CI: 1.04-1.22). CONCLUSION: Over half of recent mothers take HCs in the postpartum period. Understanding how different types of HCs impact maternal mental health can improve future postpartum care.